Skip to Main Content

An official website of the United States government

Principal Investigator
Name
Elham Dolatabadi
Degrees
PhD
Institution
York University
Position Title
Professor
Email
About this CDAS Project
Study
PLCO (Learn more about this study)
Project ID
PLCOI-1557
Initial CDAS Request Approval
May 14, 2024
Title
Leveraging Machine Learning for Gynecologic Cancer Diagnosis: Visual Question Answering
Summary
Leveraging Visual Question Answering (VQA) models trained on comprehensive radiological and histopathological datasets and images, this research aims to bridge the diagnostic gap, significantly enhancing the timeliness and accuracy of diagnoses in gynecological cancers. Integrating histopathology is critical, providing a reliable validation step against artificial intelligence (AI) predictions and incorporating established diagnostic practices into novel AI applications in Health Data Analytics. Current diagnostic methods rely heavily on imaging and biomarker tests, which come with limitations in sensitivity and specificity.
Aims

The scope of this research will encompass the application of AI in interpreting complex radiological images and clinical data to diagnose gynecological cancers more effectively and efficiently. This research aims to fill the gap by developing a specialized VQA model for gynecological cancers such as ovarian and cervical. The successful implementation of this project could revolutionize how cancers such as ovarian cancer are diagnosed, reducing the rate of late-stage discovery and improving survival rates. It also promises to reduce diagnostic wait times and enhance the overall efficiency of radiological assessments, thereby supporting more equitable health outcomes. This research is expected to significantly improve diagnostic processes for gynecological cancers, such as reducing late-stage diagnosis rates and early menopause and support more effective treatment approaches. It also aims to establish a new standard for integrating AI into clinical practice, providing a replicable model for other cancers​.

Collaborators

Sarah Taleghani, Health System Management and Health Data Analytics MA student